Skip to content

CHYM CHYM Increase (Decrease) In Product Collateral

Increase (Decrease) In Product Collateral at other companies

Raymond James Financial logo
Raymond James FinancialRJF
-$393M
JPMorgan Chase logo
JPMorgan ChaseJPM
-$1.66B-109%
Aflac logo
AflacAFL
-$2.58B-162%
Primerica logo
PrimericaPRI
-$144K+98.8%
Elevance Health logo
Elevance HealthELV
$313M+7.9%
Equitable Holdings logo
Equitable HoldingsEQH
$861M-70.0%

Other financials

Income statement

See full
Revenue$647.4M+24.8%
Gross profit$580.3M+26.6%
Operating income$46.2M+405%
Net income$53.5M+313%
EPS (diluted)$0.13

Balance sheet

See full
Cash & equivalents$607.7M+91.0%
Total debt$132.7M
Total equity$1.4B+176%
Total assets$2.0B

Cash flow

See full
Operating cash flow$87.5M+440%
CapEx$6.6M+316%
Free cash flow$80.9M+396%

Valuation

See full
Market cap$6.71B
Enterprise value$6.23B
P/S2.9×

Profitability

See full
Gross margin88.4%+0.6pp
Operating margin-43.3%-47.1pp
Net margin-41.9%-43.6pp
FCF margin6.1%

Returns & leverage

See full
Return on equity415.5%
Debt / equity0.1×
Current ratio5.1×

Where this comes from

Reported directly by CHYM in its filing.

Tagged under the XBRL concept chym:IncreaseDecreaseInProductCollateral.

The official record: CHYM’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about CHYM's increase (decrease) in product collateral.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CHYM's increase (decrease) in product collateral?
CHYM (CHYM) reported increase (decrease) in product collateral of -$19.73M in Q1 2026.
How has CHYM's increase (decrease) in product collateral changed year-over-year?
CHYM's increase (decrease) in product collateral decreased by 375.2% year-over-year, from -$4.15M to -$19.73M.
What does increase (decrease) in product collateral mean?
Tracks the net change in cash or assets held as collateral to secure specific product obligations or credit facilities. Fluctuations in this balance reflect changes in the company's liquidity requirements and risk exposure related to its financial products.